[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Monday, 3 October 2005, 15:55 GMT 16:55 UK
Boots announces 7bn merger deal
Boots store
Boots has faced stiff competition from supermarket rivals
High Street retailer Boots has said it is to merge with rival Alliance UniChem in a deal worth 7bn ($12bn).

The merger will create one of Europe's largest drugs, beauty and healthcare groups with sales of more than 13bn.

But about 1,000 jobs will go at the new firm - to be called Alliance Boots - which will have 2,600 stores in the UK.

Although an established household name in the UK, Boots has been struggling in the face of stiff competition from supermarket giants Tesco and Asda.

Boots, which began trading in 1849, has seen its sales fall in recent years as supermarkets have aggressively targeted the toiletries and over-the-counter medicines markets.

The shares of both companies rose strongly on news of the tie-up.

110m savings target

I believe that this merger does an awful lot for customers, for shareholders, and for indeed the employees
Sir Nigel Rudd, Boots chairman

The proposed merger will eventually lead to annual pre-tax cost savings of about 100m, Boots and Alliance UniChem said in a joint statement.

The boards of both companies said they would unanimously recommend the deal to their shareholders.

"We see around 1,000 [job losses] emanating from this particular transaction," said Boots' chairman Sir Nigel Rudd, adding that this was "not a significant number" considering the combined group's 100,000 staff.

There have been suggestions that Boot's headquarters in Notthingham might close, with the joint company run from Alliance UniChem's base in Chessington at the outskirts of London.

Although described as a merger of equals, Boots' chief executive Richard Baker will take on the same role at the combined group, while Sir Nigel will maintain his position as chairman at the new company.

BOOTS
Boots store
History: Established in 1849
Stores: 1,400 pharmacies
Staff: 68,000
Sales: 5.4bn (2004-5)
Profits: 481m (2004-5)

Boots shareholders will hold 50.2% of the shares in the combined group.

"I believe that this merger does an awful lot for customers, for shareholders, and for indeed the employees," Sir Nigel told BBC Breakfast.

Retail union Usdaw said it was seeking urgent talks with both Boots and Alliance UniChem.

"We are seeking meetings with both companies this week to find out exactly what the long term implications are for our members," said Usdaw general secretary John Hannett.

The stock markets appeared to approve the deal, with Boots shares gaining just over 4% or 24.5 pence to close at 633p, and Alliance UniChem rising nearly 1% to end the day with a 8.5p gain at 875p.

Global force

A tie-up will give the Boots brand greater profile in continental Europe as well as creating a major global force in the distribution of pharmaceutical and healthcare products.

Alliance UniChem's executive deputy chairman, Stefano Pessina, said the deal would "enhance our offering to the independent chemist".

But the deal is likely to be scrutinised by the UK competition authorities, which may require the merged company to sell some stores.

Profit warnings

On Sunday, the Observer reported that a merger could result in thousands of jobs losses as the two companies tried to make savings in areas such as administration and distribution.

ALLIANCE UNICHEM
Alliance UniChem store
History: Established in 1997
Stores: 1,200 pharmacies
Staff: 33,000
Sales: 8.8bn (2004-5)
Profits: 248m (2004-5)

Investors have become increasingly dissatisfied with Boots' performance over the past 18 months, during which it has issued three profits warnings.

Its profits fell 11% last year and it recently warned of "difficult" trading for the rest of the current year.

Boots' efforts to broaden its retail offering over the last ten years - offering dentistry, chiropody and laser eye surgery - have proved largely unsuccessful.

Alliance UniChem has grown steadily through acquisition to become the third largest pharmacy chain in Europe.

Boots currently owns 1,400 pharmacies in the UK and has a stock market value of 4.4bn.

Alliance UniChem operates 1,200 pharmacies in the UK, Norway, Italy, Switzerland and the Netherlands and has a market value of 3.15bn.

The combined group's wholesale and distribution network will serve over 88,000 outlets.




BBC NEWS: VIDEO AND AUDIO
Boots chairman Sir Nigel Rudd on the merger




SEE ALSO:
Intensive talks on Boots merger
02 Oct 05 |  Business
Boots set for merger with rival
01 Oct 05 |  Business
Six firms 'targeting Boots unit'
30 Sep 05 |  Business
Tough trading continues at Boots
29 Sep 05 |  Business
Boots hit by 'difficult' trading
21 Jul 05 |  Business
'Tough trading' hits Boots profit
19 May 05 |  Business


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific